{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:20:10Z","timestamp":1762507210291},"reference-count":27,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2017.5336","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T07:42:25Z","timestamp":1508312545000},"source":"Crossref","is-referenced-by-count":1,"title":["Severe erythema multiforme\u2011type drug eruption controlled by tumor necrosis factor\u2011\u03b1 antagonist: A case study"],"prefix":"10.3892","author":[{"given":"Xin","family":"Ling","sequence":"first","affiliation":[{"name":"Department of Dermatology, The First People's Hospital of Wujiang, Affiliated Wujiang Hospital of Nantong University, Suzhou, Jiangsu 215200, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Suzhou Municipal Hospital, Suzhou, Jiangsu 215006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,10,18]]},"reference":[{"key":"key20200713142845_b1-etm-0-0-5336","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2340\/00015555-0214","article-title":"Dexamethasone pulse therapy for Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"87","author":"Kardaun","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"key20200713142845_b2-etm-0-0-5336","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jaci.2005.06.029","article-title":"Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment","volume":"116","author":"Hunger","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"key20200713142845_b3-etm-0-0-5336","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/00004630-199711000-00009","article-title":"Toxic epidermal necrolysis: An analysis of referral patterns and steroid usage","volume":"18","author":"Engelhardt","year":"1997","journal-title":"J Burn Care Rehabil"},{"key":"key20200713142845_b4-etm-0-0-5336","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/archderm.131.6.669","article-title":"Characteristics of toxic epidermal necrolysis in patients undergoing long-term glucocorticoid therapy","volume":"131","author":"Guibal","year":"1995","journal-title":"Arch Dermatol"},{"key":"key20200713142845_b5-etm-0-0-5336","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","article-title":"Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR study","volume":"58","author":"Schneck","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"key20200713142845_b6-etm-0-0-5336","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1365-4632.2009.04322.x","article-title":"Prevention and treatment of systemic glucocorticoid side effects","volume":"49","author":"Moghadam-Kia","year":"2010","journal-title":"Int J Dermatol"},{"key":"key20200713142845_b7-etm-0-0-5336","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1111\/j.1346-8138.2010.00893.x","article-title":"Etoricoxib-induced toxic epidermal necrolysis: Successful treatment with infliximab","volume":"37","author":"Kreft","year":"2010","journal-title":"J Dermatol"},{"key":"key20200713142845_b8-etm-0-0-5336","first-page":"621","article-title":"Drug rash with eosinophilia and systemic symptoms controlled by tumor necrosis factor-\u03b1 antagonist: A clinical observation","volume":"46","author":"Chen","year":"2013","journal-title":"Zhonghua Pi Fu Ke Za Zhi"},{"key":"key20200713142845_b9-etm-0-0-5336","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: A severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"key":"key20200713142845_b10-etm-0-0-5336","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000335627","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"97","author":"Harr","year":"2012","journal-title":"Chem Immunol Allergy"},{"key":"key20200713142845_b11-etm-0-0-5336","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.amjmed.2016.03.022","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: An analysis of triggers and implications for improving prevention","volume":"129","author":"Miliszewski","year":"2016","journal-title":"Am J Med"},{"key":"key20200713142845_b12-etm-0-0-5336","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/ijd.12702","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: A 20-year single-center experience","volume":"54","author":"Lalosevic","year":"2015","journal-title":"Int J Dermatol"},{"key":"key20200713142845_b13-etm-0-0-5336","doi-asserted-by":"publisher","first-page":"S464","DOI":"10.1016\/j.jaci.2005.11.002","article-title":"Drug allergy","volume":"117","author":"Greenberger","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"key20200713142845_b14-etm-0-0-5336","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/path.4187","article-title":"Tumour necrosis factor in infectious disease","volume":"230","author":"Waters","year":"2013","journal-title":"J Pathol"},{"key":"key20200713142845_b15-etm-0-0-5336","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1111\/j.1476-5381.1996.tb15625.x","article-title":"The role of TNF-alpha in fever: Opposing actions of human and murine TNF-alpha and interactions with IL-beta in the rat","volume":"118","author":"Stefferl","year":"1996","journal-title":"Br J Pharmacol"},{"key":"key20200713142845_b16-etm-0-0-5336","doi-asserted-by":"publisher","first-page":"R120","DOI":"10.1186\/ar3850","article-title":"Enhanced susceptibility to lipopolysaccharide-induced arthritis and endotoxin shock in interleukin-32 alpha transgenic mice through induction of tumor necrosis factor alpha","volume":"14","author":"Nakayama","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"key20200713142845_b17-etm-0-0-5336","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.2741\/4265","article-title":"TNF\/TNFR: Drug target for autoimmune diseases and immune-mediated inflammatory diseases","volume":"19","author":"Doss","year":"2014","journal-title":"Front Biosci (Landmark Ed)"},{"key":"key20200713142845_b18-etm-0-0-5336","first-page":"41","article-title":"TNF-alpha in acute cardiac transplant rejection","volume":"5","author":"Azzawi","year":"1999","journal-title":"Cytokines Cell Mol Ther"},{"key":"key20200713142845_b19-etm-0-0-5336","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.2174\/092986709788803024","article-title":"TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma","volume":"16","author":"Esposito","year":"2009","journal-title":"Curr Med Chem"},{"key":"key20200713142845_b20-etm-0-0-5336","first-page":"85","article-title":"Time-related expression of IL-6, IL-8 and TNF-alpha following explosive injury to rabbit's chest","volume":"30","author":"He","year":"2014","journal-title":"Fa Yi Xue Za Zhi"},{"key":"key20200713142845_b21-etm-0-0-5336","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1001\/archderm.130.5.605","article-title":"Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis","volume":"130","author":"Paquet","year":"1994","journal-title":"Arch Dermatol"},{"key":"key20200713142845_b22-etm-0-0-5336","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1365-2249.1994.tb06078.x","article-title":"Immunohistological assessment of cutaneous drug hypersensitivity in patients with HIV infection","volume":"97","author":"Carr","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"key20200713142845_b23-etm-0-0-5336","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1046\/j.1523-1747.2002.01622.x","article-title":"Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis","volume":"118","author":"Nassif","year":"2002","journal-title":"J Invest Dermatol"},{"key":"key20200713142845_b24-etm-0-0-5336","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/j.1365-2133.1996.tb06976.x","article-title":"Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis","volume":"134","author":"Paul","year":"1996","journal-title":"Br J Dermatol"},{"key":"key20200713142845_b25-etm-0-0-5336","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/jid.2012.330","article-title":"TNF-\u03b1 and IFN-\u03b3 are potential inducers of Fas-mediated keratinocyte apoptosis through activation of inducible nitric oxide synthase in toxic epidermal necrolysis","volume":"133","author":"Viard-Leveugle","year":"2013","journal-title":"J Invest Dermatol"},{"key":"key20200713142845_b26-etm-0-0-5336","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/cid\/ciu126","article-title":"Severe cutaneous adverse reactions related to systemic antibiotics","volume":"58","author":"Lin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key20200713142845_b27-etm-0-0-5336","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/archderm.127.6.831","article-title":"A population-based study of Stevens-Johnson syndrome. Incidence and antecedent drug exposures","volume":"127","author":"Strom","year":"1991","journal-title":"Arch Dermatol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T13:33:02Z","timestamp":1594647182000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2017.5336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,18]]},"references-count":27,"URL":"https:\/\/doi.org\/10.3892\/etm.2017.5336","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,18]]}}}